Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (International Stem Cell CORP)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had contacted during the Term, or introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 123-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇W▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇W▇▇▇▇▇▇▇▇▇ had contacted during the Term, or introduced, directly or indirectly, to the Company during the Term, if such Tail Financing is consummated at any time within the 126-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Bellerophon Therapeutics, Inc.)
Tail Fee. ▇W▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇W▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectlyindirectly (other than the Company Investors), to the Company during Termin connection with the engagement hereunder, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreementuntil January 31, 2018.
Appears in 1 contract
Sources: Exclusive Agency Agreement (DelMar Pharmaceuticals, Inc.)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had contacted during the Term, or introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement. A list of the investors covered in the Tail Financing fee will be set forth in Exhibit I upon termination or expiration of this Agreement.
Appears in 1 contract
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“"Tail Financing”" ) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had contacted during the Tenn, or introduced, directly or indirectly, to the Company during the Term, if such Tail Financing is consummated at any time within the 129-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇W▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇W▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 126-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (CASI Pharmaceuticals, Inc.)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had contacted during the Term or introduced, directly or indirectly, to the Company during the Term, if such Tail Financing is consummated at any time within the 126-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly contacted during the Term or indirectly, introduced to the Company during the Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Innovus Pharmaceuticals, Inc.)
Tail Fee. ▇▇Wa▇▇▇▇▇▇▇▇ shall ▇hall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇Wa▇▇▇▇▇▇▇▇ had ▇ad contacted during the Term, or introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 123-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇▇▇▇▇R▇▇▇▇▇ shall be entitled to compensation described under clauses clause (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that of the proportion of such financing or capital that is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectly, to the Company who invested in an Offering that was consummated during Term, if such Tail Financing is consummated at any time within the 12-6 month period following the expiration or termination consummation of this Agreementsuch Offering.
Appears in 1 contract
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectly, to the Company during Termany Exclusive Investors, if such Tail Financing is consummated at any time within the 126-month period following the expiration or termination of this Agreement. Following termination, ▇▇▇▇▇▇ shall provide a list of investors subject to payment hereunder.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Ds Healthcare Group, Inc.)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“"Tail Financing”") to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectly, to the Company during Termprior to the termination of this Agreement, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had contacted during the Term, or introduced, directly or indirectly, to the Company during the Term, if such Tail Financing is consummated at any time within the 123-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Bellerophon Therapeutics, Inc.)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“"Tail Financing”") to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had contacted during the Term, or introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 123-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇W▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇W▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“"Tail Financing”") to the extent that such financing or capital is provided to the Company by investors in the Offering whom ▇▇▇▇▇▇▇▇▇▇ had introduced, introduced directly or indirectly, indirectly to the Company during the Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“"Tail Financing”") to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly has arranged either a call or indirectly, to meeting with the Company or invested in a Offering during the Term, if such Tail Financing is consummated at any time within the 126-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Oxis International Inc)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had contacted during the Term, or introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Innovus Pharmaceuticals, Inc.)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind common stock and common stock equivalents (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly who participated in the Offering (other than the Sabby or indirectly, to the Company during TermBroadfin funds), if such Tail Financing is consummated at any time within the 129-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (Mela Sciences, Inc. /Ny)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introduced, directly or indirectlyindirectly (other than the Company Investors), to the Company during Term, if such Tail Financing is consummated at any time within the 129-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Exclusive Agency Agreement (DelMar Pharmaceuticals, Inc.)
Tail Fee. ▇▇▇▇▇R▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind Securities (“Tail Financing”) to the extent that such financing or capital is provided to the Company by up to seven investors whom ▇▇▇▇▇R▇▇▇▇▇ had introduced, directly or indirectly, introduced to the Company during the Term, which investors will be listed on Annex B at Closing, if such Tail Financing is consummated at any time within the 12-month three (3)-month period following the expiration or termination of this Agreement.
Appears in 1 contract
Sources: Placement Agent Agreement (Northwest Biotherapeutics Inc)
Tail Fee. ▇▇▇▇▇▇▇▇▇▇ shall be entitled to compensation described under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom ▇▇▇▇▇▇▇▇▇▇ had introducedcontacted during the Term, or introduced directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 12-9 month period following the expiration or termination of this Agreement.
Appears in 1 contract